Novo Nordisk Inc. Pac (Novo Nordisk Pac) Year-End 2020 Report

Filed on Jan. 22, 2021, covers activity between Nov. 24, 2020-Dec. 31, 2020

See this filing on FEC.gov

Summary

Total Receipts

$29,688

Total Expenditures

$37,500

Cash on Hand

$65,036

Contributions

$29,688

Unitemized Contributions

12.5%

See Transactions from this Report

Top Spending Categories

The top five categories of spending as reported by the committee (these are not standardized).

Purpose
Amount
2022 Primary $15,500.00
2024 Primary $14,000.00
2024 General $3,500.00
2020 Contribution $2,500.00
2022 General $2,000.00